INTEGER HOLDINGS CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INTEGER HOLDINGS CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-07-03 was 0.00 shares, a 100.00% decline year-over-year.
- INTEGER HOLDINGS CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-04-03 was 2.88K shares, a 49.90% decline year-over-year.
- INTEGER HOLDINGS CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 2.88K shares.
- INTEGER HOLDINGS CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-26 was 0.00 shares, a 100.00% decline year-over-year.
- INTEGER HOLDINGS CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 109.85K shares, a 292.25% increase from fiscal 2024.
- INTEGER HOLDINGS CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 28.01K shares, a 66.07% decline from fiscal 2023.
- INTEGER HOLDINGS CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 82.53K shares, a 1076.02% increase from fiscal 2022.
- INTEGER HOLDINGS CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 7.02K shares, a 79.50% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-07-03 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | 5.77K shares derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-04-03 | 2.88K shares 10-Q · filed 2026-04-30 | 106.98K shares derived: sum of 4 quarters · filed 2026-04-30 |
| 2025-12-31 | 2.88K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | 109.85K shares 10-K · filed 2026-02-23 |
| 2025-09-26 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | 106.97K shares derived: sum of 4 quarters · filed 2025-10-23 |
| 2025-06-27 | 101.22K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-24 | 118.36K shares derived: sum of 4 quarters · filed 2025-07-24 |
| 2025-03-28 | 5.75K shares 10-Q · filed 2025-04-24 | 26.74K shares derived: sum of 4 quarters · filed 2025-04-24 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | 28.01K shares 10-K · filed 2025-02-20 |
| 2024-09-27 | 11.38K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | 28.01K shares derived: sum of 4 quarters · filed 2024-10-24 |
| 2024-06-28 | 9.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25 | 30.33K shares derived: sum of 4 quarters · filed 2024-07-25 |
| 2024-03-29 | 7.02K shares 10-Q · filed 2024-04-25 | 53.77K shares derived: sum of 4 quarters · filed 2024-04-25 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | 82.53K shares 10-K · filed 2024-02-20 |
| 2023-09-29 | 13.71K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | |
| 2023-06-30 | 33.04K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | |
| 2023-03-31 | 35.78K shares 10-Q · filed 2023-04-27 | |
| 2022-12-31 | 7.02K shares 10-K · filed 2023-02-21 | |
| 2021-12-31 | 7.23K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | 34.23K shares 10-K · filed 2022-02-22 |
| 2021-10-01 | 11.93K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | 33.22K shares derived: sum of 4 quarters · filed 2021-10-28 |
| 2021-07-02 | 10.85K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | 51.08K shares derived: sum of 4 quarters · filed 2021-07-29 |
| 2021-04-02 | 4.23K shares 10-Q · filed 2021-04-29 | 47.71K shares derived: sum of 4 quarters · filed 2021-04-29 |
| 2020-12-31 | 6.22K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | 102.14K shares 10-K · filed 2021-02-18 |
| 2020-10-02 | 29.79K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | 117.79K shares derived: sum of 4 quarters · filed 2020-10-29 |
| 2020-07-03 | 7.47K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | 111.43K shares derived: sum of 4 quarters · filed 2020-07-30 |
| 2020-04-03 | 58.66K shares 10-Q · filed 2020-05-08 | 110.00K shares derived: sum of 4 quarters · filed 2020-05-08 |
| 2019-12-31 | 21.87K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | 138.77K shares 10-K · filed 2020-02-20 |
| 2019-09-27 | 23.43K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | 148.43K shares derived: sum of 4 quarters · filed 2019-10-31 |
| 2019-06-28 | 6.05K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | 398.48K shares derived: sum of 4 quarters · filed 2019-08-01 |
| 2019-03-29 | 87.42K shares 10-Q · filed 2019-05-03 | 473.42K shares derived: sum of 4 quarters · filed 2019-05-03 |
| 2018-12-28 | 31.52K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | 413.32K shares 10-K · filed 2019-02-22 |
| 2018-09-28 | 273.49K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | 505.79K shares derived: sum of 4 quarters · filed 2018-11-02 |
| 2018-06-29 | 80.98K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | 505.78K shares derived: sum of 4 quarters · filed 2018-08-03 |
| 2018-03-30 | 27.32K shares 10-Q · filed 2018-05-04 | 487.49K shares derived: sum of 4 quarters · filed 2018-05-04 |
| 2017-12-29 | 124.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | 804.06K shares 10-K · filed 2018-02-22 |
| 2017-09-29 | 273.48K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-30 | 777.69K shares derived: sum of 4 quarters · filed 2017-10-30 |
| 2017-06-30 | 62.69K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | 509.51K shares derived: sum of 4 quarters · filed 2017-08-02 |
| 2017-03-31 | 343.90K shares 10-Q · filed 2017-05-09 | 474.36K shares derived: sum of 4 quarters · filed 2017-05-09 |
| 2016-12-30 | 97.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | 130.46K shares 10-K · filed 2017-02-28 |
| 2016-09-30 | 5.29K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | |
| 2016-07-01 | 27.54K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | |
| 2016-04-01 | 0.00 shares 10-Q · filed 2016-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |